Literature DB >> 8097834

Rifampicin-resistant meningococci causing invasive disease and failure of chemoprophylaxis.

P Yagupsky, S Ashkenazi, C Block.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8097834     DOI： 10.1016/0140-6736(93)93171-v

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  Meningococcal disease in healthcare workers. Vaccine is available in Latin America.

Authors:  C Trujillo
Journal:  BMJ       Date:  2000-01-22

2.  Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents.

Authors:  James H Jorgensen; Sharon A Crawford; Kristin R Fiebelkorn
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  Effectiveness of different policies in preventing meningococcal disease clusters following a single case in day-care and pre-school settings in Europe.

Authors:  D Boccia; N Andrews; S Samuelsson; S Heuberger; A Perrocheau; J M Stuart
Journal:  Epidemiol Infect       Date:  2006-01-18       Impact factor: 2.451

4.  First recorded outbreaks of meningococcal disease in the Israel Defence Force: three clusters due to serogroup C and the emergence of resistance to rifampicin.

Authors:  R Almog; C Block; M Gdalevich; B Lev; M Wiener; S Ashkenazi
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553

5.  Rifampin resistance in Neisseria meningitidis due to alterations in membrane permeability.

Authors:  F J Abadi; P E Carter; P Cash; T H Pennington
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

6.  Molecular characterization of rifampin-resistant Neisseria meningitidis.

Authors:  P E Carter; F J Abadi; D E Yakubu; T H Pennington
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

Review 7.  Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review.

Authors:  Bernadette Purcell; Susanne Samuelsson; Susan J M Hahné; Ingrid Ehrhard; Sigrid Heuberger; Ivonne Camaroni; André Charlett; James M Stuart
Journal:  BMJ       Date:  2004-06-05

8.  Management of a rifampicin-resistant meningococcal infection in a teenager.

Authors:  D Delaune; D Andriamanantena; A Mérens; E Viant; O Aoun; F Ceppa; M-K Taha; C Rapp
Journal:  Infection       Date:  2013-02-14       Impact factor: 3.553

9.  Fitness Cost of Rifampin Resistance in Neisseria meningitidis: In Vitro Study of Mechanisms Associated with rpoB H553Y Mutation.

Authors:  Roberta Colicchio; Chiara Pagliuca; Gabiria Pastore; Annunziata Gaetana Cicatiello; Caterina Pagliarulo; Adelfia Talà; Elena Scaglione; Josè Camilla Sammartino; Cecilia Bucci; Pietro Alifano; Paola Salvatore
Journal:  Antimicrob Agents Chemother       Date:  2015-09-28       Impact factor: 5.191

10.  Rifampin-resistant meningococcal disease.

Authors:  Jean Rainbow; Elizabeth Cebelinski; Joanne Bartkus; Anita Glennen; Dave Boxrud; Ruth Lynfield
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.